vimarsana.com

Latest Breaking News On - Sangamo therapeutic - Page 2 : vimarsana.com

Time To Worry? Analysts Are Downgrading Their Sangamo Therapeutics, Inc (NASDAQ:SGMO) Outlook

One thing we could say about the analysts on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) - they aren't optimistic.

We re A Little Worried About Sangamo Therapeutics (NASDAQ:SGMO) Cash Burn Rate

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the.

Comparing Sangamo Therapeutics (NASDAQ:SGMO) & Immatics (NASDAQ:IMTX)

Immatics (NASDAQ:IMTX – Get Rating) and Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings. Profitability This table compares Immatics and Sangamo Therapeutics’ net margins, […]

Q1 2023 EPS Estimates for Sangamo Therapeutics, Inc (NASDAQ:SGMO) Lifted by HC Wainwright

Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Rating) – Stock analysts at HC Wainwright lifted their Q1 2023 earnings per share (EPS) estimates for Sangamo Therapeutics in a report issued on Monday, May 1st. HC Wainwright analyst P. Trucchio now forecasts that the biopharmaceutical company will post earnings of $0.14 per share for the quarter, up […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.